Fibromyalgia
📧 Sign up to get email alerts when something new happens for Fibromyalgia.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS withdrawal · 2026-04-24Clinical Trial Update: Effectiveness of the Sana Device on Fibromyalgia Symptoms [NA]
A clinical trial evaluating the Sana Device for fibromyalgia symptoms has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2025-08-14Clinical Trial Update: Investigational Use of Erenumab for the Treatment of Fibromyalgia Pain [Phase 3]
A Phase 3 trial evaluating erenumab for fibromyalgia has been withdrawn, ending development for this indication.
-
CLINICAL_TRIALS withdrawal · 2025-06-29Clinical Trial Update: Study of the Influence of POLD Manual Therapy in Fibromyalgia [NA]
The clinical trial evaluating POLD Manual Therapy for fibromyalgia has been withdrawn from the registry.
-
CLINICAL_TRIALS withdrawal · 2024-11-21Clinical Trial Update: Phase II Clinical Trial: Multi-dosing the BCG Vaccine for Fibromyalgia [Phase 2]
A Phase II trial testing multi-dosing Bacillus Calmette-Guérin (BCG) vaccine for fibromyalgia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2024-05-16Clinical Trial Update: Rhythmic Sensory Stimulation on Fibromyalgia [NA]
The clinical trial investigating rhythmic sensory stimulation for fibromyalgia has been withdrawn.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS withdrawal · 2019-11-04Clinical Trial Update: A Study for Adolescents With Fibromyalgia Syndrome [Phase 4]
A Phase 4 clinical trial in adolescents with fibromyalgia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2019-08-09Clinical Trial Update: Cymbalta for Fibromyalgia Pain - Predictive Value of Small Fiber Changed [Phase 4]
A Phase 4 trial investigating Cymbalta (duloxetine) for fibromyalgia pain was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-11-29Clinical Trial Update: Maintenance of Efficacy. [Phase 3]
A Phase 3 clinical trial investigating maintenance of efficacy in fibromyalgia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2018-05-18Clinical Trial Update: Effect of CPAP on Symptoms of Patients With Fibromyalgia and Obstructive Sleep Apnea [NA]
The clinical trial evaluating the effect of CPAP on symptoms in patients with fibromyalgia and obstructive sleep apnea has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2017-11-08Clinical Trial Update: The Effects of Mindfulness Meditation on Fibromyalgia-Related Pain [NA]
The clinical trial investigating mindfulness meditation for fibromyalgia-related pain has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-12-11Clinical Trial Update: Low Dose Naltrexone for the Treatment of Juvenile Primary Fibromyalgia Syndrome [NA]
A clinical trial evaluating low-dose naltrexone for juvenile primary fibromyalgia syndrome has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-12-04Clinical Trial Update: Calcitonin in the Treatment of Fibromyalgia [Phase 4]
A Phase 4 clinical trial investigating calcitonin for fibromyalgia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-09-18Clinical Trial Update: The Effect of Milnacipran on Fatigue and Quality of Life in Lupus Patients [Phase 4]
Phase 4 trial evaluating milnacipran for fatigue and quality of life in lupus patients has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2015-07-27Clinical Trial Update: Whole Body Hyperthermia (WBH) as a Rapid Treatment for Fibromyalgia [NA]
A clinical trial investigating whole body hyperthermia as a rapid treatment for fibromyalgia has been withdrawn.
-
CLINICAL_TRIALS withdrawal · 2014-04-14Clinical Trial Update: Fibromyalgia of Less Than One Year Duration. Study of Pregabalin [Phase 4]
A Phase 4 study evaluating pregabalin for fibromyalgia of less than one year duration was withdrawn.
-
CLINICAL_TRIALS withdrawal · 2011-06-01Clinical Trial Update: Zonisamide for Fibromyalgia & Migraine [Phase 4]
A Phase 4 clinical trial evaluating zonisamide for fibromyalgia and migraine has been withdrawn.
-
EMA withdrawal · 2010-04-26EMA Refused: Impulsor (milnacipran) — Pierre Fabre Medicament
The EMA refused approval for Impulsor (milnacipran) for fibromyalgia, following a decision by Pierre Fabre Medicament.
-
EMA withdrawal · 2010-04-26EMA Refused: Milnacipran Pierre Fabre Medicament (milnacipran) — Pierre Fabre Medicament
EMA has refused the marketing authorization for Milnacipran Pierre Fabre Medicament for fibromyalgia.